AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (October 29, 2004). doi:10.1152/ajplung.00274.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/L618    most recent
00274.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hite, R. D.
Right arrow Articles by Waite, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hite, R. D.
Right arrow Articles by Waite, B. M.
Submitted on July 19, 2004
Accepted on October 13, 2004

Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A2-mediated surfactant dysfunction

R. Duncan Hite1*, Michael C. Seeds2, Anca M. Safta1, Randolph B. Jacinto1, Julianna I. Gyves3, David A. Bass4, and B. Moseley Waite5

1 Department of Internal Medicine/Section on Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA
2 Department of Internal Medicine/Section on Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA; Section on Molecular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA
3 Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
4 Section on Molecular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Internal Medicine/Section on Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA
5 Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Internal Medicine/Section on Pulmonary and Critical Care Medicine, Wake Forest University Schooll of Medicine, Winston-Salem, NC, USA

* To whom correspondence should be addressed. E-mail: dhite{at}wfubmc.edu.

Pulmonary surfactant's complex mixture of phospholipids and proteins reduce the work of breathing by lowering alveolar surface tension during respiration. One mechanism of surfactant damage appears to be the hydrolysis of phospholipid by phospholipases activated in the inflamed lung. Humans have several candidate secretory phospholipase A2 enzymes in lung cells and infiltrating leukocytes that could damage extracellular surfactant. We considered two mechanisms of surfactant disruption by five human sPLA2s; including generation of lysophospholipids and the depletion of specific phospholipids. All five sPLA2s studied ultimately caused surfactant dysfunction. Each enzyme exhibited a different pattern of hydrolysis of surfactant phospholipids. Phosphatidylcholine, the major phospholipid in surfactant and the greatest potential source for generation of lysophospholipids was susceptible to hydrolysis by group IB, group V and group X sPLA2s, but not groups IIA or IID. Group IIA hydrolyzed both phosphatidylethanolamine and phosphatidylglycerol while group IID was active against only phosphatidylglycerol. Thus, with groups IB and X, the generation of lysophospholipids corresponded with surfactant dysfunction. However, hydrolysis of and depletion of phosphatidylglycerol had a greater correlation with surfactant dysfunction for groups IIA and IID. Surfactant dysfunction caused by group V sPLA2 is less clear and may be the combined result of both mechanisms.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
B. P. Hurley and B. A. McCormick
Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation
Infect. Immun., June 1, 2008; 76(6): 2259 - 2272.
[Full Text] [PDF]


Home page
ChestHome page
G. Enhorning
Surfactant in Airway Disease
Chest, April 1, 2008; 133(4): 975 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. B. Fisher, C. Dodia, S. I. Feinstein, and Y.-S. Ho
Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2
J. Lipid Res., June 1, 2005; 46(6): 1248 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. G. Cochrane
Pulmonary surfactant in allergic inflammation: new insights into the molecular mechanisms of surfactant function
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L608 - L609.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. D. Hite, M. C. Seeds, D. L. Bowton, B. L. Grier, A. M. Safta, R. Balkrishnan, B. M. Waite, and D. A. Bass
Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L610 - L617.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.